218 related articles for article (PubMed ID: 9827256)
41. [Antibiotherapy as first choice in infectious meningitis].
Cohen R; de La Rocque F; Varon E; Geslin P
Pediatrie; 1993; 48(1):37-49. PubMed ID: 8392691
[TBL] [Abstract][Full Text] [Related]
42. The pharmacokinetics and pharmacodynamics of meropenem in the cerebrospinal fluid of neurosurgical patients.
Tsumura R; Ikawa K; Morikawa N; Ikeda K; Shibukawa M; Iida K; Kurisu K
J Chemother; 2008 Oct; 20(5):615-21. PubMed ID: 19028626
[TBL] [Abstract][Full Text] [Related]
43. Diffusion of 3-quaternary ammonium cephem antibiotics into cerebrospinal fluid of patients with bacterial meningitis.
Modai J
J Chemother; 1996 Feb; 8 Suppl 2():83-90. PubMed ID: 8738850
[TBL] [Abstract][Full Text] [Related]
44. Use of antibacterial agents in infections of the central nervous system.
Thea D; Barza M
Infect Dis Clin North Am; 1989 Sep; 3(3):553-70. PubMed ID: 2671139
[TBL] [Abstract][Full Text] [Related]
45. Prevalence and antibiotic resistance profiles of cerebrospinal fluid pathogens in children with acute bacterial meningitis in Yunnan province, China, 2012-2015.
Jiang H; Su M; Kui L; Huang H; Qiu L; Li L; Ma J; Du T; Fan M; Sun Q; Liu X
PLoS One; 2017; 12(6):e0180161. PubMed ID: 28662145
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetic and bacteriological correlations between antimicrobial therapy of experimental meningitis in rabbits and meningitis in humans: a review.
McCracken GH
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():97-108. PubMed ID: 6365874
[TBL] [Abstract][Full Text] [Related]
47. Tobramycin levels in cerebrospinal fluid of patients with slightly and severely impaired blood-cerebrospinal barrier.
Brückner O; Alexander M; Collmann H
Chemotherapy; 1981; 27(5):303-8. PubMed ID: 7261686
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of Meropenem Penetration into Cerebrospinal Fluid in Patients with Meningitis After Neurosurgery.
Zhang Y; Zhang J; Chen Y; Yu J; Cao G; Wu X; Chen M; Wu J; Zhao X
World Neurosurg; 2017 Feb; 98():525-531. PubMed ID: 27867128
[TBL] [Abstract][Full Text] [Related]
49. Antibacterial agents in infections of the central nervous system.
Chowdhury MH; Tunkel AR
Infect Dis Clin North Am; 2000 Jun; 14(2):391-408, ix. PubMed ID: 10829262
[TBL] [Abstract][Full Text] [Related]
50. [Transferability of vancomycin to cerebrospinal fluid in rabbits with meningitis caused by Staphylococcus aureus].
Haruta T; Okura K; Kuroki S; Nigami H; Kobayashi Y
Jpn J Antibiot; 1993 Feb; 46(2):154-8. PubMed ID: 8331775
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics and protein binding of linezolid in cerebrospinal fluid and serum in a case of post-neurosurgical bacterial meningitis.
Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Sadoh S; Kobayashi T; Takemura Y; Sakamoto S; Morita K; Kamimura H; Karube Y
Scand J Infect Dis; 2011 Dec; 43(11-12):982-5. PubMed ID: 21851332
[TBL] [Abstract][Full Text] [Related]
52. Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens.
Craig W
Eur J Clin Microbiol Infect Dis; 1993; 12 Suppl 1():S6-8. PubMed ID: 8477766
[TBL] [Abstract][Full Text] [Related]
53. Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae.
Täuber MG; Doroshow CA; Hackbarth CJ; Rusnak MG; Drake TA; Sande MA
J Infect Dis; 1984 Apr; 149(4):568-74. PubMed ID: 6327835
[TBL] [Abstract][Full Text] [Related]
54. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
Roberts JA; Lipman J
Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
[TBL] [Abstract][Full Text] [Related]
55. Antibiotic pharmacokinetic and pharmacodynamic parameters in pediatric clinical practice.
Cohen R; Grimprel E
Arch Pediatr; 2017 Dec; 24(12S):S6-S8. PubMed ID: 29290237
[TBL] [Abstract][Full Text] [Related]
56. [Transferability of biapenem (L-627) to cerebrospinal fluid in rabbits with meningitis caused by Staphylococcus aureus].
Haruta T; Kuroki S; Okura K; Nikami H; Nishio T; Kobayashi Y
Jpn J Antibiot; 1994 Jul; 47(7):869-72. PubMed ID: 7933519
[TBL] [Abstract][Full Text] [Related]
57. [Pharmacokinetic effects of antibiotics on the development of bacterial resistance particularly in reference to azithromycin].
Wenisch C
Wien Med Wochenschr; 2000; 150(3):37-41. PubMed ID: 10756595
[TBL] [Abstract][Full Text] [Related]
58. Estimation of steady state antibiotic concentration in cerebrospinal fluid from single-dose kinetics.
Nau R; Prange HW
Eur J Clin Pharmacol; 1996; 49(5):407-9. PubMed ID: 8866638
[TBL] [Abstract][Full Text] [Related]
59. Cefepime cerebrospinal fluid concentrations in neonatal bacterial meningitis.
Ellis JM; Rivera L; Reyes G; Castillo F; Marte P; Tejada M; Salazar JC
Ann Pharmacother; 2007 May; 41(5):900-1. PubMed ID: 17426074
[No Abstract] [Full Text] [Related]
60. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
Klutman NE
Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
